Rotavirus vaccine

DB10276ApprovedInvestigationalVaccinesLive Attenuated Rotavirus VaccineLive Rotavirus Vaccine

Rotavirus commonly infects children and infants causing severe diarrhea and vomiting leading to potentially fatal dehydration. Two rotavirus vaccines are available for the prevention of rotavirus gastroenteritis, Rotateq and Rotarix.... Rotateq is a live vaccine consisting of 5 reassorted human-bovine viral strains.

Protein structure of Rotavirus vaccine
Mechanism
Curator reviewed
Primary indication
Rotarix is indicated for prevention of rotavirus gastroenteritis caused by G1, G3, G4, and G9 types in infants aged 6-24 weeks.Curator reviewed · 9 structured indications
First approval
Canada, 2006 · United States, 2006 · European Union, 2021
Also known as
Rota virus, live attenuated · Rotavirus vaccine, live, oral
Brand names
  • Rotarix
  • Rotateq

Resolves to

Clinical / RWD

What you can answer from here — as of July 17, 2026

290Drug interactionsStructured to mechanism, not free text
Sign in
104Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
94Marketed productsAcross 8 countries and 7 labellers
Sign in
1ATC codeIncluding every combination product, plus 9 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Rotavirus vaccine, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account